Skip to content

Neltenexine

RESPIRATORY SYSTEM

Also known as: alveoten, neltenexine HCl, neltenexine hydrochloride, neltenexine monohydrate

Korean Food and Drug Administration (KFDA) approvedATC R05CB14

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Neltenexine is a drug catalogued in DrugCentral. It was first approved by the Korean Food and Drug Administration (KFDA) in 2001. Recorded indications include Chronic bronchitis.

  • Indications: Chronic bronchitis.
  • ATC code: R05CB14 (Mucolytics).
  • Molecular formula: C18H20Br2N2O2S; molecular weight 488.24 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Chronic bronchitis

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2001-10-16Korean Food and Drug Administration (KFDA)——

ATC classification

ATC codeTherapeutic hierarchy
R05CB14RESPIRATORY SYSTEM › COUGH AND COLD PREPARATIONS › EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS › Mucolytics

Chemical structure

Molecular formulaC18H20Br2N2O2S
Molecular weight488.24 g/mol
CAS number99453-84-6
InChIKeySSLHKNBKUBAHJY-HDJSIYSDSA-N
PubChem CID3047787
O[C@H]1CC[C@@H](CC1)NCC1=C(NC(=O)C2=CC=CS2)C(Br)=CC(Br)=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Neltenexine used for?

DrugCentral lists the following indications for Neltenexine: Chronic bronchitis.

When was Neltenexine first approved?

Neltenexine was first approved by the Korean Food and Drug Administration (KFDA) in 2001.

What is the chemical formula of Neltenexine?

Neltenexine has the molecular formula C18H20Br2N2O2S and a molecular weight of 488.24 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2001-10-16
AgencyKorean Food and Drug Administration (KFDA)
Targets0
Indications1
FormulaC18H20Br2N2O2S
DrugCentral ID1894
Interactive profile